Canada Heparin Market Size & Outlook, 2023-2030
Canada heparin market, 2018-2030 (US$M)
Related Markets
Canada heparin market highlights
- The Canada heparin market generated a revenue of USD 320.4 million in 2023 and is expected to reach USD 396.9 million by 2030.
- The Canada market is expected to grow at a CAGR of 3.1% from 2024 to 2030.
- In terms of segment, porcine was the largest revenue generating source in 2023.
- Porcine is the most lucrative source segment registering the fastest growth during the forecast period.
Heparin market data book summary
| Market revenue in 2023 | USD 320.4 million |
| Market revenue in 2030 | USD 396.9 million |
| Growth rate | 3.1% (CAGR from 2023 to 2030) |
| Largest segment | Porcine |
| Fastest growing segment | Porcine |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Porcine |
| Key market players worldwide | Pfizer Inc, Sanofi SA, Aspen Pharmacare Holdings Ltd, Fresenius SE & Co KGaA, Novartis AG ADR, GSK PLC ADR, Dr. Reddy’s Laboratories, LEO Pharma, B. Braun Medical |
Other key industry trends
- In terms of revenue, Canada accounted for 4.3% of the global heparin market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. heparin market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 396.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Heparin Market Scope
Heparin Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Canada heparin market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to heparin market will help companies and investors design strategic landscapes.
Porcine was the largest segment with a revenue share of 91.29% in 2023. Horizon Databook has segmented the Canada heparin market based on porcine covering the revenue growth of each sub-segment from 2018 to 2030.
Canada’s heparin market is driven by an increase in the prevalence of chronic diseases, such as cardiovascular disorders, DVT, pulmonary embolism, and renal diseases. Thrombosis Canada and the Canadian Society for Vascular Surgery are organizations actively involved in promoting the vascular health of the Canadian population through research, education, advocacy, & collaborations.
As per the AHA Journal, over 405,000 individuals are impacted by DVT in Canada, a prevalence of approximately 1.15%. The incidence of acute myocardial infarction is 1.75 per 1000 population. The rate of diabetes in Canada is high; 1 in 3 Canadians is either diabetic or prediabetic.
Diabetes being a risk factor for venous thromboembolism and stroke, creates a large market for heparin in the region. In August 2019, Fresenius Kabi Canada Ltd. indicated a potential shortage of heparin supply, due to a shortage of API in China.
Reasons to subscribe to Canada heparin market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada heparin market databook
-
Our clientele includes a mix of heparin market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada heparin market , including forecasts for subscribers. This country databook contains high-level insights into Canada heparin market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Canada heparin market size, by source, 2018-2030 (US$M)
Canada Heparin Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
